Last reviewed · How we verify

NCT05021068

Spinal Structure and Mobility in Chronic Obstructive Pulmonary Disease

Completed Last updated 30 August 2021
What this trial tests

trial testing Postural Assessment in COPD in 98 participants. Completed in 1 March 2021.

Timeline
1 March 2018
Primary endpoint
1 March 2021
1 March 2021

Quick facts

Lead sponsorIzmir Katip Celebi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment98
Start date1 March 2018
Primary completion1 March 2021
Estimated completion1 March 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir Katip Celebi University

Who can join

18 and older, any sex, with COPD or Postural; Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In recent studies with musculoskeletal system disorders in chronic respiratory patients, it has been reported that postural control is affected in COPD patients. The aim of this study to investigate relationship between spinal structure and mobility an severity of dyspnea in patients with COPD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Izmir Katip Celebi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05021068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing